2025 Pharma Deals Annual Review — A leaner yet higher-value year for dealmaking制药/制药装备医疗/医药IQVIA2026-03-2621 页
China Pharma & Biotech: ASCO 2026 Part 3 - Summary (for when fundamentals begin to matter again)制药/制药装备医疗/医药Bernstein2026-06-0325 页
Global Healthcare: The Obesity Evolution: Framing global AOM peptide manufacturing capacity and implications for the branded/generic markets制药/制药装备医疗/医药Goldman Sachs2026-06-0545 页
医药生物行业报告（2026.06.01-2026.06.07）稳健经营基础上高分红，中药企业估值修复与股息收益凸显投资价值中医药/中药制药/制药装备券商证券医疗/医药中邮证券研究所2026-06-0816 页
